EVerZom

company

About

EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
€2.50M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jul 1, 1919
Number Of Employee
1 - 10
Operating Status
Active

EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles. They develop a bioproduction platform to produce extracellular vesicles at a commercial scale in a GMP compliant way for pharmaceutical companies with applications in regenerative medicine and drug delivery. Extracellular vesicles that encompass exosomes, microvesicles, and apoptotic bodies are the tools used by cells to communicate with each other.

EVerZom was founded in 2019 and is headquartered in Paris, Ile-de-France, France.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€2.50M
EVerZom has raised a total of €2.50M in funding over 2 rounds. Their latest funding was raised on Nov 18, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 18, 2021 Grant €2.50M 1 European Innovation Council Detail

Investors

Number of Lead Investors
Number of Investors
1
1
EVerZom is funded by 1 investors. European Innovation Council are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant